Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Peer-Reviewed Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Nlrp5em1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Nlrp5em1flox/Cya

Common Name
Nlrp5-flox
Product ID
S-CKO-18919
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-23968-Nlrp5-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Nlrp5-flox Mouse (Catalog S-CKO-18919) were purchased from Cyagen.”
cKO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
Basic Information
Strain Name
Nlrp5-flox
Strain ID
CKOCMP-23968-Nlrp5-B6J-VA
Gene Name
Nlrp5
Product ID
S-CKO-18919
Gene Alias
Op1, Mater, Nalp5, PAN11
Background
C57BL/6JCya
NCBI ID
23968 (Mouse)
Modification
Conditional knockout
Chromosome
Chr 7 (Mouse)
Phenotype
MGI:1345193
Datasheet
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000015866
NCBI Transcript ID
NM_011860
Target Region
Exon 8
Size of Effective Region
~2.6 kb
Overview of Gene Research
Nlrp5, a maternal-effect gene, is crucial for normal pre-implantation and embryonic development [1,2,4,5,7,8]. It is part of the subcortical maternal complex (SCMC) and may be involved in stabilizing UHRF1 protein in the cytoplasm, which is relevant to maintaining CpG methylation of imprinting control regions during pre-implantation development [3].

In mouse models, Nlrp5 mutant oocytes have abnormal mitochondrial localization and increased activity, leading to reactive oxygen species accumulation, mitochondrial depletion, and early embryonic arrest at the two-cell stage. In sows, knockdown of NLRP5 arrests early embryogenesis [7,8]. In humans, mutations in NLRP5 are associated with female infertility, including oocyte maturation abnormality, total fertilization failure, and early embryonic arrest [2,5,9]. In sheep, certain mutations in NLRP5 are associated with litter size [6].

In conclusion, Nlrp5 plays an essential role in early embryogenesis across different species. Studies using gene-knockout or knockdown models in mice and sows, along with human genetic studies, have revealed its significance in processes like mitochondrial function regulation in oocytes and embryos, and its mutations are linked to infertility-related diseases.

References:
1. Huang, Xingchen, Sun, Qinqiang, Chen, Dongrong, Zhang, Ming, Fu, Qiang. 2022. Nlrp5 and Tle6 expression patterns in buffalo oocytes and pre-implantation embryos. In Reproduction in domestic animals = Zuchthygiene, 57, 481-488. doi:10.1111/rda.14084. https://pubmed.ncbi.nlm.nih.gov/35044003/
2. Tong, Xiaomei, Jin, Jiamin, Hu, Zhanhong, Zhang, Yin-Li, Zhang, Songying. 2022. Mutations in OOEP and NLRP5 identified in infertile patients with early embryonic arrest. In Human mutation, 43, 1909-1920. doi:10.1002/humu.24448. https://pubmed.ncbi.nlm.nih.gov/35946397/
3. Unoki, Motoko, Uemura, Shuhei, Fujimoto, Akihiro, Sasaki, Hiroyuki. . The maternal protein NLRP5 stabilizes UHRF1 in the cytoplasm: implication for the pathogenesis of multilocus imprinting disturbance. In Human molecular genetics, 33, 1575-1583. doi:10.1093/hmg/ddae096. https://pubmed.ncbi.nlm.nih.gov/38868925/
4. Sang, Qing, Zhou, Zhou, Mu, Jian, Wang, Lei. 2021. Genetic factors as potential molecular markers of human oocyte and embryo quality. In Journal of assisted reproduction and genetics, 38, 993-1002. doi:10.1007/s10815-021-02196-z. https://pubmed.ncbi.nlm.nih.gov/33895934/
5. Huang, Lingli, Wang, Yu, Lu, Fangting, Jin, Rentao, Tong, Xianhong. 2022. Novel mutations in NLRP5 and PATL2 cause female infertility characterized by primarily oocyte maturation abnormality and consequent early embryonic arrest. In Journal of assisted reproduction and genetics, 39, 711-718. doi:10.1007/s10815-022-02412-4. https://pubmed.ncbi.nlm.nih.gov/35091966/
6. Zhang, Zhuangbiao, Tang, Jishun, He, Xiaoyun, Di, Ran, Chu, Mingxing. 2020. Mutations in NLRP5 and NLRP9 are Associated with Litter Size in Small Tail Han Sheep. In Animals : an open access journal from MDPI, 10, . doi:10.3390/ani10040689. https://pubmed.ncbi.nlm.nih.gov/32326631/
7. Peng, Hui, Liu, Fang, Li, Wenhao, Zhang, Wenchang. 2015. Knockdown of NLRP5 arrests early embryogenesis in sows. In Animal reproduction science, 163, 151-6. doi:10.1016/j.anireprosci.2015.11.004. https://pubmed.ncbi.nlm.nih.gov/26585895/
8. Fernandes, Roxanne, Tsuda, Chiharu, Perumalsamy, Alagammal L, Nelson, Lawrence M, Jurisicova, Andrea. 2012. NLRP5 mediates mitochondrial function in mouse oocytes and embryos. In Biology of reproduction, 86, 138, 1-10. doi:10.1095/biolreprod.111.093583. https://pubmed.ncbi.nlm.nih.gov/22357545/
9. Li, Mingzhao, Jia, Miaomiao, Zhao, Xiaoli, Shi, Rong, Xue, Xia. 2020. A new NLRP5 mutation causes female infertility and total fertilization failure. In Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 37, 283-284. doi:10.1080/09513590.2020.1832069. https://pubmed.ncbi.nlm.nih.gov/33073652/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research